HomeWhat is GSHArticlesFAQsGSH & DiseasesContact Us

 

 

 

 

home > articles > parkinson's disease > parkinson's disease: a disorder due to nigral glutathione deficiency?

Glutathione Articles - Parkinson's Disease

Parkinson's Disease: A Disorder Due to Nigral Glutathione Deficiency?
Perry TL, Godin DV, Hansen S.
Neurosci Lett. 1982 Dec 13;33(3):305-10.
> download PDF version of this abstract

ABSTRACT

Amino acid analysis of autopsied human brain showed reduced glutathione (GSH) content significantly lower in the substantia nigra than in other brain regions. GSH was virtually absent in the nigra of patients with Parkinson's disease. Oxidative degradation of L-DOPA and dopamine in vivo may generate reactive oxygen species (hydrogen peroxide, superoxide, hydroxyl radical, or singlet oxygen) which can damage membranes and other cellular components. Since GSH is an important natural antioxidant, a deficiency of GSH in the substantia nigra could make this region vulnerable to oxidative injur y. If confirmed, the hypothesis that loss of nigrostriatal dopaminergic neurons results from a regional GSH deficiency could have important therapeutic implications for the management and prevention of Parkinson's disease.

> download PDF version of this abstract


If you would like us to send you the full text version of the article listed above, please contact us by phone or e-mail:

Caron Coats

Toll Free:
Tel: 800-227-2627
Fax: 800-369-0302
Local:
Tel: 205-879-6551
Fax: 205-871-2568
Email:
ccoats@wellnesshealth.com

 

     
 


Glutathione Experts | What is Glutathione (GSH)? | Glutathione Articles | GSH FAQs | GSH & Diseases | Contact